🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHeart rate increase on GLP-1 — November 2025 Page 5

Heart rate increase on GLP-1 — November 2025

Dr.ObesityMed Thu, May 30, 2024 at 5:58 AM 31 replies 2,498 viewsPage 5 of 7
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Jun 1, 2024 at 11:06 PM#21

Clinical perspective, offered as context rather than as advice.

Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history. Results were encouraging:

  • NT-proBNP: 45 pg/mL (normal, cardiac function preserved)
  • Lp(a): 35 nmol/L (genetic, unchanged — expected)
  • ApoB: dropped from 145 to 85 mg/dL (excellent response)
  • Coronary calcium score: 0 (unchanged from baseline — reassuring)

The ApoB reduction is particularly meaningful — it's considered the best single predictor of cardiovascular risk. GLP-1 therapy seems to improve this consistently.

49 22SallyK_inj, CryptoCarl, MariaRD and 46 others
Reply Quote Save Share Report
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Jun 2, 2024 at 5:28 PM#22
sophie_paris said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.

Second this. I had assumed I was the exception until I read this.

Last edited: Jun 2, 2024 at 11:28 PM
50 23GraceAZ_72, carl_compliance, DanielChem_CHI and 47 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jun 3, 2024 at 11:49 AM#23
sophie_paris said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.

Lp(a) and cardiovascular risk: a nuance that matters. Unlike most lipid markers, Lp(a) is 90%+ genetically determined and doesn't really change with weight loss or GLP-1 therapy.

My Lp(a) has remained at 76 nmol/L across all time points. If yours is elevated (>50 nmol/L), you need additional risk mitigation strategies regardless of your GLP-1 response. Don't assume your medication is covering all cardiovascular risk factors.

Last edited: Jun 3, 2024 at 2:49 PM
1 24DataDave
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jun 4, 2024 at 6:10 AM#24
sophie_paris said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.

Senior perspective on cardiovascular risk: I'm 70 years old and started this journey skeptically. My internist recommended it after years of failed interventions.

8 months later: down 38 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

2 0ricardo_MIA, BrianDallas92
Reply Quote Save Share Report
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Jun 5, 2024 at 12:31 AM#25

Following on from sophie_paris — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Jun 5, 2024 at 2:31 AM
3 1tampaLisa73, KarenAZ_mom, zoe_NC
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register